These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 16162101

  • 1. Is blood eosinophilia an effective predictor of acute rejection in living donor liver transplantation?
    Kishi Y, Sugawara Y, Tamura S, Kaneko J, Akamatsu N, Togashi J, Makuuchi M.
    Transpl Int; 2005 Oct; 18(10):1147-51. PubMed ID: 16162101
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection.
    Demirhan B, Bilezikçi B, Haberal AN, Sevmiş S, Arat Z, Haberal M.
    Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397
    [Abstract] [Full Text] [Related]

  • 6. Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count.
    Rodríguez-Perálvarez M, Germani G, Tsochatzis E, Rolando N, Luong TV, Dhillon AP, Thorburn D, O'Beirne J, Patch D, Burroughs AK.
    Transpl Int; 2012 May; 25(5):555-63. PubMed ID: 22420754
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation].
    Fan S, Zhang Z.
    Zhonghua Yi Xue Za Zhi; 2001 Sep 25; 81(18):1092-4. PubMed ID: 11766604
    [Abstract] [Full Text] [Related]

  • 8. Is biliary bile acid a good predictor for acute cellular rejection in living donor liver transplantation?
    Hedaya MS, El Moghazy WM, Yasutomo Y, Kiyoshi T, Kaido T, Egawa H, Uemoto S, Takada Y.
    Hepatobiliary Pancreat Dis Int; 2009 Oct 25; 8(5):474-8. PubMed ID: 19822489
    [Abstract] [Full Text] [Related]

  • 9. Association between blood eosinophil counts and acute cardiac and pulmonary allograft rejection.
    Trull A, Steel L, Cornelissen J, Smith T, Sharples L, Cary N, Stewart S, Large S, Wallwork J.
    J Heart Lung Transplant; 1998 May 25; 17(5):517-24. PubMed ID: 9628572
    [Abstract] [Full Text] [Related]

  • 10. Correlation between acute rejection severity and CD8-positive T cells in living related liver transplantation.
    Kubota N, Sugitani M, Takano S, Sheikh A, Takayama T, Haga H, Tanaka K, Yamabe H.
    Transpl Immunol; 2006 Jun 25; 16(1):60-4. PubMed ID: 16701178
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT.
    Am J Surg Pathol; 2008 Oct 25; 32(10):1479-88. PubMed ID: 18708942
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated blood eosinophil count is a valuable biomarker for predicting late acute cellular rejection after liver transplantation.
    Wang GY, Li H, Liu W, Zhang J, Zhu HB, Wang GS, Zhang Q, Yang Y, Chen GH.
    Transplant Proc; 2013 Apr 25; 45(3):1198-200. PubMed ID: 23622658
    [Abstract] [Full Text] [Related]

  • 15. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome.
    Hassoun Z, Shah V, Lohse CM, Pankratz VS, Petrovic LM.
    Liver Transpl; 2004 Apr 25; 10(4):480-7. PubMed ID: 15048789
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H, Yagi T, Iwagaki H, Matsuda H, Shinoura S, Umeda Y, Ohara N, Yanai H, Ogino T, Tanaka N.
    J Gastroenterol Hepatol; 2009 Apr 25; 24(4):574-80. PubMed ID: 19368635
    [Abstract] [Full Text] [Related]

  • 17. Significance of alanine aminopeptidase N (APN) in bile in the diagnosis of acute cellular rejection after liver transplantation.
    Kim C, Aono S, Marubashi S, Wada H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Okumura N, Takao T, Doki Y, Mori M, Nagano H.
    J Surg Res; 2012 Jun 01; 175(1):138-48. PubMed ID: 21550066
    [Abstract] [Full Text] [Related]

  • 18. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia.
    Sanada Y, Kawano Y, Miki A, Aida J, Nakamura K, Shimomura N, Ishikawa N, Arai T, Hirata Y, Yamada N, Okada N, Wakiya T, Ihara Y, Urahashi T, Yasuda Y, Takubo K, Mizuta K.
    Transpl Int; 2014 Apr 01; 27(4):383-90. PubMed ID: 24472036
    [Abstract] [Full Text] [Related]

  • 19. The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation.
    Florman S, Schiano T, Kim L, Maman D, Levay A, Gondolesi G, Fishbein T, Emre S, Schwartz M, Miller C, Sheiner P.
    Clin Transplant; 2004 Apr 01; 18(2):152-5. PubMed ID: 15016129
    [Abstract] [Full Text] [Related]

  • 20. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R, Asonuma K, Zeledon Ramirez ME, Yoshimoto K, Nishimori A, Inomata Y.
    Exp Clin Transplant; 2009 Mar 01; 7(1):8-12. PubMed ID: 19364305
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.